Paper40649986
Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.
Radenković N and 5 others. Int J Mol Sci, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells. Papers, record 40649986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40649986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quercetin | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Colonic Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Molecular Docking Simulation | |
| Cell Line, Tumor | |
| Cytochrome P-450 CYP1A1 | |
| HT29 Cells | |
| Cytochrome P-450 CYP1B1 | |
| ATP-Binding Cassette, Sub-Family C Proteins | |
| Apoptosis | |
| Gene Expression Regulation, Neoplastic | |
| Fluorouracil |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28479391 | Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression. | Food Chem Toxicol | 2017 | https://conductscience.org/library/papers/28479391 | PubMed |
| 2 | 32461960 | Isorhamnetin Induces Melanoma Cell Apoptosis via the PI3K/Akt and NF-κB Pathways. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32461960 | PubMed |
| 3 | 25829782 | Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. | Pharmacogn Mag | 2015 | https://conductscience.org/library/papers/25829782 | PubMed |
| 4 | 35406504 | Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406504 | PubMed |
| 5 | 29643473 | Revisiting the role of ABC transporters in multidrug-resistant cancer. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/29643473 | PubMed |
| 6 | 32636741 | Phytochemicals: Potential Lead Molecules for MDR Reversal. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32636741 | PubMed |
| 7 | 39241942 | Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. | Eur J Pharmacol | 2024 | https://conductscience.org/library/papers/39241942 | PubMed |
| 8 | 30487385 | Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30487385 | PubMed |
| 9 | 21059794 | Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. | Toxicol Sci | 2011 | https://conductscience.org/library/papers/21059794 | PubMed |
| 10 | 2291479 | Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. | Anal Biochem | 1990 | https://conductscience.org/library/papers/2291479 | PubMed |
| 11 | 16518375 | Targeting multidrug resistance in cancer. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16518375 | PubMed |
| 12 | 32938494 | AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4. | Biol Direct | 2020 | https://conductscience.org/library/papers/32938494 | PubMed |
| 13 | 15845415 | Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. | Toxicol Appl Pharmacol | 2005 | https://conductscience.org/library/papers/15845415 | PubMed |
| 14 | 15897250 | The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. | Mol Cancer Ther | 2005 | https://conductscience.org/library/papers/15897250 | PubMed |
| 15 | 36737602 | Structure and Mechanism of Human ABC Transporters. | Annu Rev Biophys | 2023 | https://conductscience.org/library/papers/36737602 | PubMed |
| 16 | 6606682 | Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. | J Immunol Methods | 1983 | https://conductscience.org/library/papers/6606682 | PubMed |
| 17 | 21256954 | Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. | Toxicol In Vitro | 2011 | https://conductscience.org/library/papers/21256954 | PubMed |
| 18 | 34243600 | Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/34243600 | PubMed |
| 19 | 37492547 | In vitro study of pinostrobin propionate and pinostrobin butyrate: Cytotoxic activity against breast cancer cell T47D and its selectivity index. | J Public Health Afr | 2023 | https://conductscience.org/library/papers/37492547 | PubMed |
| 20 | 31590241 | Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31590241 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42513098 | Plant- and Algae-Derived Compounds Enhance the Anticancer Activity of Doxorubicin in Colorectal Cancer Cell Lines. | Molecules | 2026 | https://conductscience.org/library/papers/42513098 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| ABCB6 | 10058 | PubTator's text mining | https://conductscience.org/library/genes/10058 | NCBI Gene |
| ABCC1 | 4363 | PubTator's text mining | https://conductscience.org/library/genes/4363 | NCBI Gene |
| ABCC5 | 10057 | PubTator's text mining | https://conductscience.org/library/genes/10057 | NCBI Gene |
| CYP1A1 | 1543 | PubTator's text mining | https://conductscience.org/library/genes/1543 | NCBI Gene |
| CYP1B1 | 1545 | PubTator's text mining | https://conductscience.org/library/genes/1545 | NCBI Gene |
| GSTK1 | 373156 | PubTator's text mining | https://conductscience.org/library/genes/373156 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40649986
GET https://conductscience.org/api/papers/v1/40649986/references?page=2